This research report provides a comprehensive analysis of the Sialylated Human Milk Oligosaccharides (HMO) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Sialylated Human Milk Oligosaccharides (HMO) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Sialylated Human Milk Oligosaccharides (HMO), challenges faced by the industry, and potential opportunities for market players.
The global Sialylated Human Milk Oligosaccharides (HMO) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Sialylated Human Milk Oligosaccharides (HMO) market presents opportunities for various stakeholders, including Infant Formula, Food. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Sialylated Human Milk Oligosaccharides (HMO) market. Additionally, the growing consumer demand present avenues for market expansion.
The global Sialylated Human Milk Oligosaccharides (HMO) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Sialylated Human Milk Oligosaccharides (HMO) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Sialylated Human Milk Oligosaccharides (HMO) market.
Market Overview: The report provides a comprehensive overview of the Sialylated Human Milk Oligosaccharides (HMO) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 3'-Sialyllactose, 6'-Sialyllactose), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Sialylated Human Milk Oligosaccharides (HMO) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Sialylated Human Milk Oligosaccharides (HMO) market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Sialylated Human Milk Oligosaccharides (HMO) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Sialylated Human Milk Oligosaccharides (HMO) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Sialylated Human Milk Oligosaccharides (HMO) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Sialylated Human Milk Oligosaccharides (HMO) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Sialylated Human Milk Oligosaccharides (HMO), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Sialylated Human Milk Oligosaccharides (HMO) market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Sialylated Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
3'-Sialyllactose
6'-Sialyllactose
Market segment by Application
Infant Formula
Food
Others
Global Sialylated Human Milk Oligosaccharides (HMO) Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sialylated Human Milk Oligosaccharides (HMO), market overview.
Chapter 2: Global Sialylated Human Milk Oligosaccharides (HMO) market size in revenue and volume.
Chapter 3: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sialylated Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sialylated Human Milk Oligosaccharides (HMO) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sialylated Human Milk Oligosaccharides (HMO) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sialylated Human Milk Oligosaccharides (HMO) Overall Market Size
2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size: 2023 VS 2030
2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales: 2019-2030
3 Company Landscape
3.1 Top Sialylated Human Milk Oligosaccharides (HMO) Players in Global Market
3.2 Top Global Sialylated Human Milk Oligosaccharides (HMO) Companies Ranked by Revenue
3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Companies
3.4 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Companies
3.5 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Sialylated Human Milk Oligosaccharides (HMO) Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sialylated Human Milk Oligosaccharides (HMO) Players in Global Market
3.8.1 List of Global Tier 1 Sialylated Human Milk Oligosaccharides (HMO) Companies
3.8.2 List of Global Tier 2 and Tier 3 Sialylated Human Milk Oligosaccharides (HMO) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Markets, 2023 & 2030
4.1.2 3'-Sialyllactose
4.1.3 6'-Sialyllactose
4.2 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue & Forecasts
4.2.1 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2024
4.2.2 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2025-2030
4.2.3 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
4.3 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales & Forecasts
4.3.1 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2024
4.3.2 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2025-2030
4.3.3 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
4.4 By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2023 & 2030
5.1.2 Infant Formula
5.1.3 Food
5.1.4 Others
5.2 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue & Forecasts
5.2.1 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2024
5.2.2 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2025-2030
5.2.3 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
5.3 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales & Forecasts
5.3.1 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2024
5.3.2 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2025-2030
5.3.3 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
5.4 By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2023 & 2030
6.2 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue & Forecasts
6.2.1 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2024
6.2.2 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2025-2030
6.2.3 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
6.3 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales & Forecasts
6.3.1 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2024
6.3.2 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales, 2025-2030
6.3.3 By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030
6.4.2 By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2030
6.4.3 US Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.4.4 Canada Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.4.5 Mexico Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030
6.5.2 By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2030
6.5.3 Germany Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.4 France Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.5 U.K. Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.6 Italy Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.7 Russia Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.8 Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.5.9 Benelux Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030
6.6.2 By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2030
6.6.3 China Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.6.4 Japan Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.6.5 South Korea Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.6.6 Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.6.7 India Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030
6.7.2 By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2030
6.7.3 Brazil Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.7.4 Argentina Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales, 2019-2030
6.8.3 Turkey Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.8.4 Israel Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.8.5 Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
6.8.6 UAE Sialylated Human Milk Oligosaccharides (HMO) Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
7.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Summary
7.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview
7.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Key News & Latest Developments
7.2 DSM (Glycom A/S)
7.2.1 DSM (Glycom A/S) Company Summary
7.2.2 DSM (Glycom A/S) Business Overview
7.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.2.5 DSM (Glycom A/S) Key News & Latest Developments
7.3 Inbiose
7.3.1 Inbiose Company Summary
7.3.2 Inbiose Business Overview
7.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.3.5 Inbiose Key News & Latest Developments
7.4 Kyowa Hakko Bio
7.4.1 Kyowa Hakko Bio Company Summary
7.4.2 Kyowa Hakko Bio Business Overview
7.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.4.5 Kyowa Hakko Bio Key News & Latest Developments
7.5 GeneChem Inc.
7.5.1 GeneChem Inc. Company Summary
7.5.2 GeneChem Inc. Business Overview
7.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.5.5 GeneChem Inc. Key News & Latest Developments
7.6 FrieslandCampina Ingredients
7.6.1 FrieslandCampina Ingredients Company Summary
7.6.2 FrieslandCampina Ingredients Business Overview
7.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Major Product Offerings
7.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales and Revenue in Global (2019-2024)
7.6.5 FrieslandCampina Ingredients Key News & Latest Developments
8 Global Sialylated Human Milk Oligosaccharides (HMO) Production Capacity, Analysis
8.1 Global Sialylated Human Milk Oligosaccharides (HMO) Production Capacity, 2019-2030
8.2 Sialylated Human Milk Oligosaccharides (HMO) Production Capacity of Key Manufacturers in Global Market
8.3 Global Sialylated Human Milk Oligosaccharides (HMO) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sialylated Human Milk Oligosaccharides (HMO) Supply Chain Analysis
10.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Value Chain
10.2 Sialylated Human Milk Oligosaccharides (HMO) Upstream Market
10.3 Sialylated Human Milk Oligosaccharides (HMO) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Sialylated Human Milk Oligosaccharides (HMO) in Global Market
Table 2. Top Sialylated Human Milk Oligosaccharides (HMO) Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Companies, 2019-2024
Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Companies, (Tons), 2019-2024
Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Price (2019-2024) & (US$/Kg)
Table 8. Global Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Product Type
Table 9. List of Global Tier 1 Sialylated Human Milk Oligosaccharides (HMO) Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sialylated Human Milk Oligosaccharides (HMO) Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2019-2024
Table 15. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2025-2030
Table 16. By Application ? Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2019-2024
Table 20. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2025-2030
Table 21. By Region ? Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2019-2024
Table 25. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), 2025-2030
Table 26. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2019-2024
Table 29. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2025-2030
Table 30. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2019-2024
Table 33. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2025-2030
Table 34. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2019-2024
Table 37. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2025-2030
Table 38. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2019-2024
Table 41. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2025-2030
Table 42. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2019-2024
Table 45. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales, (Tons), 2025-2030
Table 46. Chr. Hansen (Jennewein Biotechnologie GmgH) Company Summary
Table 47. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 48. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 49. Chr. Hansen (Jennewein Biotechnologie GmgH) Key News & Latest Developments
Table 50. DSM (Glycom A/S) Company Summary
Table 51. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 52. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 53. DSM (Glycom A/S) Key News & Latest Developments
Table 54. Inbiose Company Summary
Table 55. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 56. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 57. Inbiose Key News & Latest Developments
Table 58. Kyowa Hakko Bio Company Summary
Table 59. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 60. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 61. Kyowa Hakko Bio Key News & Latest Developments
Table 62. GeneChem Inc. Company Summary
Table 63. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 64. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 65. GeneChem Inc. Key News & Latest Developments
Table 66. FrieslandCampina Ingredients Company Summary
Table 67. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Offerings
Table 68. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 69. FrieslandCampina Ingredients Key News & Latest Developments
Table 70. Sialylated Human Milk Oligosaccharides (HMO) Production Capacity (Tons) of Key Manufacturers in Global Market, 2022-2024 (Tons)
Table 71. Global Sialylated Human Milk Oligosaccharides (HMO) Capacity Market Share of Key Manufacturers, 2022-2024
Table 72. Global Sialylated Human Milk Oligosaccharides (HMO) Production by Region, 2019-2024 (Tons)
Table 73. Global Sialylated Human Milk Oligosaccharides (HMO) Production by Region, 2025-2030 (Tons)
Table 74. Sialylated Human Milk Oligosaccharides (HMO) Market Opportunities & Trends in Global Market
Table 75. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers in Global Market
Table 76. Sialylated Human Milk Oligosaccharides (HMO) Market Restraints in Global Market
Table 77. Sialylated Human Milk Oligosaccharides (HMO) Raw Materials
Table 78. Sialylated Human Milk Oligosaccharides (HMO) Raw Materials Suppliers in Global Market
Table 79. Typical Sialylated Human Milk Oligosaccharides (HMO) Downstream
Table 80. Sialylated Human Milk Oligosaccharides (HMO) Downstream Clients in Global Market
Table 81. Sialylated Human Milk Oligosaccharides (HMO) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Segment by Type in 2023
Figure 2. Sialylated Human Milk Oligosaccharides (HMO) Segment by Application in 2023
Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, 2019-2030 (US$, Mn)
Figure 7. Sialylated Human Milk Oligosaccharides (HMO) Sales in Global Market: 2019-2030 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Sialylated Human Milk Oligosaccharides (HMO) Revenue in 2023
Figure 9. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 11. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 12. By Type - Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg), 2019-2030
Figure 13. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 15. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 16. By Application - Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg), 2019-2030
Figure 17. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 20. By Region - Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 21. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 22. By Country - North America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 23. US Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 28. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 29. France Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 37. China Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 41. India Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 43. By Country - South America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 44. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share, 2019-2030
Figure 48. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$, Mn), 2019-2030
Figure 52. Global Sialylated Human Milk Oligosaccharides (HMO) Production Capacity (Tons), 2019-2030
Figure 53. The Percentage of Production Sialylated Human Milk Oligosaccharides (HMO) by Region, 2023 VS 2030
Figure 54. Sialylated Human Milk Oligosaccharides (HMO) Industry Value Chain
Figure 55. Marketing Channels
